Table 1.
Thyroid tumor | Morphology | IHC | Genetic alterations |
---|---|---|---|
HTT | Nests and cords of cells showing oval-spindle nuclei with nuclear pseudoinclusions and abundant intratrabecular hyaline material | KI67/ MIB-1 [cell membrane positivity] Thyroglobulin |
PAX8/GLIS1 PAX8/GLIS3 Wild type BRAF and RAS |
PTC | Papillary and follicular structures with nuclei having irregular border, grooves and pseudoinclusions | HBME-1, Galectin-3 and CK19 | BRAF V600E mutation |
NIFTP | Encapsulated tumor made of follicular structures (with no papillae) and more or less prominent nuclear irregularities and pseudoinclusions (as for PTC) | Thyroglobulin and PAX8 |
RAS mutations THADA fusion PAX8/PPARγ BRAF K601E mutation [Wild type BRAF V600E] |
MTC | Spindle or plasmacytoid cells with round oval eccentric nuclei containing salt and pepper chromatin in a more or less abundant amorphous stroma (amyloid-rich) |
Calcitonin CEA |
Different alterations according to sporadic or familial MTC involving RET gene |
Paraganglioma | Circumscribed tumor with nesting (zell ballen) or trabecular architecture made of roundish or spindle cells with minimal atypia | Neuroendocrine markers and S100 | SDHA (or B or C or D) germline mutations |
FA | Encapsulated tumor made of follicular structures with round homogeneous nuclei | Thyroglobulin | RAS mutation |
HTT hyalinizing trabecular tumor, PTC papillary thyroid carcinoma, NIFTP non-invasive follicular thyroid neoplasm with papillary-like nuclear features, MTC medullary thyroid carcinoma, FA follicular adenoma, IHC immunohistochemistry